Back to Search
Start Over
Three-dimensional echocardiographic left ventricular strain analysis in Fabry disease: correlation with heart failure severity, myocardial scar, and impact on long-term prognosis.
- Source :
-
European heart journal. Cardiovascular Imaging [Eur Heart J Cardiovasc Imaging] 2023 Nov 23; Vol. 24 (12), pp. 1629-1637. - Publication Year :
- 2023
-
Abstract
- Aims: Fabry disease (FD) is a multisystemic lysosomal storage disorder caused by a defect in the alpha-galactosidase A gene that manifests as a phenocopy of hypertrophic cardiomyopathy. We assessed the echocardiographic 3D left ventricular (LV) strain of patients with FD in relation to heart failure severity using natriuretic peptides, the presence of a cardiovascular magnetic resonance (CMR) late gadolinium enhancement scar, and long-term prognosis.<br />Methods and Results: 3D echocardiography was feasible in 75/99 patients with FD [aged 47 ± 14 years, 44% males, LV ejection fraction (EF) 65 ± 6% and 51% with hypertrophy or concentric remodelling of the LV]. Long-term prognosis (death, heart failure decompensation, or cardiovascular hospitalization) was assessed over a median follow-up of 3.1 years. A stronger correlation was observed for N-terminal pro-brain natriuretic peptide levels with 3D LV global longitudinal strain (GLS, r = -0.49, P < 0.0001) than with 3D LV global circumferential strain (GCS, r = -0.38, P < 0.001) or 3D LVEF (r = -0.25, P = 0.036). Individuals with posterolateral scar on CMR had lower posterolateral 3D circumferential strain (CS; P = 0.009). 3D LV-GLS was associated with long-term prognosis [adjusted hazard ratio 0.85 (confidence interval 0.75-0.95), P = 0.004], while 3D LV-GCS and 3D LVEF were not (P = 0.284 and P = 0.324).<br />Conclusion: 3D LV-GLS is associated with both heart failure severity measured by natriuretic peptide levels and long-term prognosis. Decreased posterolateral 3D CS reflects typical posterolateral scarring in FD. Where feasible, 3D-strain echocardiography can be used for a comprehensive mechanical assessment of the LV in patients with FD.<br />Competing Interests: Conflict of interest: D.R. reports consulting honoraria from Sanofi Genzyme. J.M. reports consulting honoraria from Sanofi Genzyme, Takeda, Amicus. G.D. reports consulting honoraria from Sanofi Genzyme, Takeda, Amicus, Protalix. A.L. reports consulting honoraria from Sanofi Genzyme, Takeda, Amicus, Avrobio.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology.)
- Subjects :
- Male
Humans
Female
Cicatrix diagnostic imaging
Contrast Media
Reproducibility of Results
Gadolinium
Ventricular Function, Left
Stroke Volume
Echocardiography methods
Prognosis
Fabry Disease complications
Fabry Disease diagnostic imaging
Heart Failure diagnostic imaging
Heart Failure etiology
Echocardiography, Three-Dimensional methods
Ventricular Dysfunction, Left diagnostic imaging
Ventricular Dysfunction, Left etiology
Subjects
Details
- Language :
- English
- ISSN :
- 2047-2412
- Volume :
- 24
- Issue :
- 12
- Database :
- MEDLINE
- Journal :
- European heart journal. Cardiovascular Imaging
- Publication Type :
- Academic Journal
- Accession number :
- 37309820
- Full Text :
- https://doi.org/10.1093/ehjci/jead121